In August 2023, FDA issued warning letters to organizations that failed to supply satisfactory documentation towards the company about demanded screening made to prevent DEG/EG contamination or that failed to answer FDA’s requests for information.A highly trained deal progress and producing Corporation (CDMO) that understands the formulation cha